Works matching IS 07248741 AND DT 2022 AND VI 39 AND IP 8

Results: 22

Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1749, doi. 10.1007/s11095-022-03333-8

By:

Jeon, Jae Yoon;
Ayyar, Vivaswath S.;
Mitra, Amitava

Publication type:

Article

Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1663, doi. 10.1007/s11095-022-03327-6

By:

Mitra, Amitava;
Wang, Yaning

Publication type:

Article

Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1881, doi. 10.1007/s11095-022-03312-z

By:

Metry, Melissa;
Krug, Samuel A.;
Karra, Vijaya Kumari;
Ekins, Sean;
Hoag, Stephen W.;
Kane, Maureen A.;
Fink, Jeffrey C.;
Polli, James E.

Publication type:

Article

In-Vivo Tape Stripping Study with Caffeine for Comparisons on Body Sites, Age and Washing.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1935, doi. 10.1007/s11095-022-03311-0

By:

Wargniez, William;
Connétable, Sophie;
Bourokba, Nasrine;
Dufour, Olivia;
Nouveau, Stéphanie;
Grégoire, Sébastien

Publication type:

Article

Correction to: Liposomal Formulation for Oral Delivery of Cyclosporine A: Usefulness as a Semisolid-Dispersion System.

Published in:

2022

By:

Minami, Keiko;
Kataoka, Makoto;
Takagi, Toshihide;
Asai, Tomohiro;
Oku, Naoto;
Yamashita, Shinji

Publication type:

Correction Notice

Microneedle-Mediated Permeation Enhancement of Chlorhexidine Digluconate: Mechanistic Insights Through Imaging Mass Spectrometry.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1945, doi. 10.1007/s11095-022-03309-8

By:

Kirkby, Melissa;
Sabri, Akmal Bin;
Scurr, David;
Moss, Gary

Publication type:

Article

Investigation of an Uncommon Artifact during Reducing Capillary Electrophoresis-Sodium Dodecyl Sulfate Analysis of a Monoclonal Antibody with Dynamic Light Scattering and Reversed Phase High-Performance Liquid Chromatography.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1959, doi. 10.1007/s11095-022-03303-0

By:

Gao, Han;
Wang, Si-Tao;
Hu, Feng;
Shen, Bin-Bin;
Sun, Min-Fei;
Wang, Haibin;
Li, Lei;
Fang, Wei-Jie

Publication type:

Article

Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1823, doi. 10.1007/s11095-022-03301-2

By:

Moreno-Mendieta, Silvia;
Guillén, Daniel;
Vasquez-Martínez, Nathaly;
Hernández-Pando, Rogelio;
Sánchez, Sergio;
Rodríguez-Sanoja, Romina

Publication type:

Article

Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1851, doi. 10.1007/s11095-022-03297-9

By:

Barshidi, Asal;
Karpisheh, Vahid;
Noukabadi, Fatemeh Karimian;
Kiani, Fariba Karoon;
Mohammadi, Mohammad;
Afsharimanesh, Negin;
Ebrahimi, Farbod;
Kiaie, Seyed Hossein;
Navashenaq, Jamshid Gholizadeh;
Hojjat-Farsangi, Mohammad;
Zolbanin, Naime Majidi;
Mahmoodpoor, Ata;
Hassannia, Hadi;
Nami, Sanam;
Jalali, Pooya;
Jafari, Reza;
Jadidi-Niaragh, Farhad

Publication type:

Article

Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1789, doi. 10.1007/s11095-022-03295-x

By:

Siler, Scott Q.

Publication type:

Article

Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1891, doi. 10.1007/s11095-022-03265-3

By:

Chen, Hao;
Lu, Yun;
Shi, Shuai;
Zhang, Qiang;
Cao, Xiaoli;
Sun, Lei;
An, Dong;
Zhang, Xiaojie;
Kong, Xianglin;
Liu, Jianping

Publication type:

Article

Mechanistic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Delivery of Cetuximab in Rats.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1867, doi. 10.1007/s11095-022-03294-y

By:

Gao, Xizhe;
Lee, Jongbong;
Deshpande, Kiran;
Kang, David W.;
Fathallah, Anas M.;
Kagan, Leonid

Publication type:

Article

Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1669, doi. 10.1007/s11095-022-03288-w

By:

Madabushi, Rajanikanth;
Seo, Paul;
Zhao, Liang;
Tegenge, Million;
Zhu, Hao

Publication type:

Article

The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1681, doi. 10.1007/s11095-022-03280-4

By:

Anand, Om;
Pepin, Xavier J. H.;
Kolhatkar, Vidula;
Seo, Paul

Publication type:

Article

Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1701, doi. 10.1007/s11095-022-03274-2

By:

Lin, Wen;
Chen, Yuan;
Unadkat, Jashvant D.;
Zhang, Xinyuan;
Wu, Di;
Heimbach, Tycho

Publication type:

Article

Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1907, doi. 10.1007/s11095-022-03273-3

By:

Yang, Lin;
Yang, Nan;
Yi, Bin;
Pei, Qi;
Huang, Zhijun

Publication type:

Article

Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1921, doi. 10.1007/s11095-022-03289-9

By:

Dong, Ji;
Liu, Shuai-bing;
Rasheduzzaman, Jony Md;
Huang, Chen-rong;
Miao, Li-yan

Publication type:

Article

Dose Finding in Oncology: What is Impeding Coming of Age?

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1817, doi. 10.1007/s11095-022-03263-5

By:

Mayawala, Kapil;
de Alwis, Dinesh

Publication type:

Article

Role of Disease Progression Models in Drug Development.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1803, doi. 10.1007/s11095-022-03257-3

By:

Barrett, Jeffrey S.;
Nicholas, Tim;
Azer, Karim;
Corrigan, Brian W.

Publication type:

Article

Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1733, doi. 10.1007/s11095-022-03250-w

By:

Frechen, Sebastian;
Rostami-Hodjegan, Amin

Publication type:

Article

Applications of Model-Based Meta-Analysis in Drug Development.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1761, doi. 10.1007/s11095-022-03201-5

By:

Chan, Phyllis;
Peskov, Kirill;
Song, Xuyang

Publication type:

Article

Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients.

Published in:

Pharmaceutical Research, 2022, v. 39, n. 8, p. 1779, doi. 10.1007/s11095-022-03194-1

By:

Llanos-Paez, Carolina;
Ambery, Claire;
Yang, Shuying;
Beerahee, Misba;
Plan, Elodie L.;
Karlsson, Mats O.

Publication type:

Article